Skip to content

Use of Death Cafes to Prevent Burnout in ICU Healthcare Employees

Systematic Trial Of PrevenTing Healthcare Employee Burnout: Using Reflection & Nourishment

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04347811
Acronym
STOPTHEBURN
Enrollment
340
Registered
2020-04-15
Start date
2020-07-20
Completion date
2022-12-26
Last updated
2023-02-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Anxiety, Burnout, Burnout, Professional, Burnout, Psychological, Depression

Keywords

Critical Care, Nurses, Physicians, Healthcare Workers, Death, Grief, Stress, Psychological, Occupational Stress, Behavioral Symptoms, Coping Skills, Clinical Trial

Brief summary

Burnout affects a significant number of healthcare employees and leads to worsened mental health, increased job turnover, and patient safety events. Those caring for critically ill patients may be especially susceptible due to high patient mortality, long hours, and regular encounters with traumatic and ethical issues. Preliminary studies suggest that debriefing opportunities may reduce burnout through reflection on distressing patient events, enhancement of social support, and interprofessional collaboration. Death Cafés are a specific form of debriefing that focus on discussing death, dying, loss, and illness. The purpose of this study is to evaluate whether biweekly Death Cafe group debriefing sessions can prevent burnout in ICU physicians and staff.

Interventions

BEHAVIORALDeath Cafe

Death Cafés are a specific form of debriefing that focuses on discussing death, dying, loss, and illness. Nourishment in the form of cake is provided. These sessions may allow for reflection on distressing patient events while developing a sense of community and collaboration among hospital employees.

Sponsors

Spirit of Charity Foundation - University Medical Center
CollaboratorUNKNOWN
Tulane University School of Medicine
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
NONE

Eligibility

Sex/Gender
ALL
Healthy volunteers
Yes

Inclusion criteria

* Physicians, nurses, pharmacists, or therapists working in the Intensive Care Unit and have worked for the full-time equivalent of at least 1 week in the preceding 4 weeks

Exclusion criteria

* Not physicians, nurses, pharmacists, or therapists * Have worked less than the full-time equivalent of at least 1 week in the preceding 4 weeks

Design outcomes

Primary

MeasureTime frameDescription
Differences in Burnout as measured by the Maslach Burnout Inventory Score (MBI).At the time of enrollment and at 1 month, 3 months, 6 months after enrollmentThis is a validated 22-item, self-reported questionnaire that asks respondents to indicate on a 7 point Likert scale the frequency of certain feelings related to their job. Presence of burnout is defined by high values of depersonalization and emotional exhaustion with low values for personal accomplishment. Changes in mean scores between groups and within groups over time will be assessed.

Secondary

MeasureTime frameDescription
Differences in Depression as measured by the Patient Health Questionnaire 8 (PHQ-8)At the time of enrollment and at 1 month, 3 months, 6 months after enrollmentThis is an 8 question validated questionnaire that asks respondents to indicate the frequency with which they have experienced certain symptoms consistent with depression. Higher scores mean higher frequency of depression symptoms, and a score of 10 or higher will be considered to indicate clinically significant depression. Changes in mean scores between groups and within groups over time will be assessed.
Differences in Anxiety as measured by the Generalized Anxiety Disorder 7 Scale (GAD-7)At the time of enrollment and at 1 month, 3 months, 6 months after enrollmentThis is a 7 question validated questionnaire that asks respondents to indicate the frequency with which they have experienced certain symptoms consistent with anxiety. Higher scores mean higher frequency of anxiety symptoms, and a score of 10 or higher will be considered to indicate clinically significant anxiety. Changes in mean scores between groups and within groups over time will be assessed.

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 24, 2026